Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
This report contains market size and forecasts of Injection Peptide Drug in Global, including the following market information:
Global Injection Peptide Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Injection Peptide Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Intravenous Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Injection Peptide Drug include Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie and Ipsen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Injection Peptide Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injection Peptide Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Injection Peptide Drug Market Segment Percentages, by Type, 2021 (%)
Intravenous Injection
Subcutaneous Injection
Global Injection Peptide Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Injection Peptide Drug Market Segment Percentages, by Application, 2021 (%)
Cancer
Metabolic Disorders
Central Nervous System
Other
Global Injection Peptide Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Injection Peptide Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Injection Peptide Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Injection Peptide Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J